HOME >> MEDICINE >> NEWS
Medication may promote opening of arteries following stroke

A medication known as argatroban, when combined with another drug already used in the treatment of stroke patients, may help restore the flow of blood through blocked arteries, according to a preliminary study in the August issue of Archives of Neurology, one of the JAMA/Archives journals.

Ischemic stroke, the most common type of stroke, generally occurs when a blood clot lodges in an artery, blocking blood flow to the brain. Some patients with ischemic stroke are treated quickly with intravenous recombinant tissue plasminogen activator (rtPA), which works to help dissolve the clot and reopen the artery. However, some patients do not respond to rtPA alone, according to background information in the article. In animals, argatroban--which blocks the action of chemicals that clot the blood--has been shown to work with rtPA, increasing blood flow, speeding the opening of blood vessels and preventing recurring blockages. Argatroban is approved for use in patients with heart attacks to help prevent clots but has not been tested in human stroke victims.

Rebecca M. Sugg, M.D., University of TexasHouston Medical School, and colleagues evaluated the safety and efficacy of the drug combination in 15 stroke patients (10 men and five women, average age 61 years) who had blockages in the cerebral arteries, major blood vessels leading to the brain. Patients received the standard dose of rtPA intravenously an average of 118 minutes after their symptoms began, with the initial dose of the drug administered in one minute and the rest infused over the period of an hour. Within one hour of rtPA treatment (an average of 172 minutes after symptoms began), the patients received a large dose of argatroban followed by a continuous 48-hour infusion. Patients were watched closely for signs of excessive bleeding (hemorrhage), the most common risk associated with drugs that prevent clotting; all but one participant, who showed initial signs of hemorrhage, received
'"/>

Contact: Deborah Mann Lake
713-500-3030
JAMA and Archives Journals
14-Aug-2006


Page: 1 2

Related medicine news :

1. Medication does not appear to offer benefit for certain heart attack patients undergoing PCI
2. Medication errors affect childrens leukemia treatment
3. IOM Advisory: Preventing Medication Errors News Conference on July 20
4. Medication use linked to farmers injuries
5. Medication plus oral contraceptive may improve female pattern hair loss
6. Medication reduces risk of adverse events for patients with acute coronary syndromes undergoing PCI
7. Medications that lower blood pressure linked to reduced risk of Alzheimers disease
8. Medication shows modest benefit in reducing weight, improving HDL, triglyceride levels
9. Medication plus beta-blocker helps prevent shocks from implantable cardioverter defibrillator
10. Medications and cough syrups may cause cavities
11. Medication reduces risk of heart irregularities after cardiac surgery

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Medication may promote opening arteries following stroke

(Date:2/26/2015)... (PRWEB) February 27, 2015 ... mobility management services, and one of the founders ... have engaged business development firm The Endurance Group ... Wireless Analytics’ latest iteration of the CLEAN Platform™ ... services. The Endurance Group, based in Yarmouth, ...
(Date:2/26/2015)... Marking its fifth successful year of business, ... announced the development of a new and improved UV-Aid light ... this spring. UV-Aid is a unique and patent pending technology ... in areas of the body susceptible to infection. UVA light ... the daily dose of UV-Aid is equivalent to less than ...
(Date:2/26/2015)... 26, 2015 Miami auto accident lawyer, Sean ... with a new, useful addition by making it possible for ... issues. , “Given the fact that last year (2014) was ... that keeping drivers - especially those car accident victims who ... on recall issues is important.” – Personal injury lawyer, Sean ...
(Date:2/26/2015)... Angeles, CA (PRWEB) February 26, 2015 ... Hair Restoration have monitored the evolution of one of ... The ARTAS system offers a machinery ... with accuracy from the patient’s scalp,” said Dr. Parsa ... FUE grafts automated, the speed at which the device ...
(Date:2/26/2015)... Wound Care Advantage (WCA), ... its executive team by adding three key members possessing ... same time two WCA team members were promoted to ... was founded in 2002 and is one of the ... WCA team believes that providing outstanding patient care is ...
Breaking Medicine News(10 mins):Health News:Wireless Analytics Engages The Endurance Group to Promote Upcoming CLEAN Platform™ 4.0 Launch 2Health News:Wireless Analytics Engages The Endurance Group to Promote Upcoming CLEAN Platform™ 4.0 Launch 3Health News:UV Technologies, LLC Developing New More Effective UV-Aid for Flu and Cold Prevention 2Health News:Auto Recalls Additional Feature, Sean M. Cleary Miami Auto Accident Lawyer 2Health News:Newest Technology now Available at Parsa Mohebi Hair Restoration 2Health News:Wound Center Management Leader WCA Expands Its Team to Include Additional Industry Experts 2Health News:Wound Center Management Leader WCA Expands Its Team to Include Additional Industry Experts 3Health News:Wound Center Management Leader WCA Expands Its Team to Include Additional Industry Experts 4
(Date:2/26/2015)... LONDON , February 26, 2015 ... release, please scroll to bottom . Investor-Edge ... Johnson (NYSE: JNJ ), Teva Pharmaceutical Industries ... (NASDAQ: ENDP ), Allergan Inc. (NYSE: ... DEPO ). Free research report on Johnson and Johnson ...
(Date:2/26/2015)... Ultrasound World will celebrate its 11 ... to provide the latest advances, trends, and equipment ... around the world. UE Systems will ... the field of air- and structure-borne ultrasound to ... this year,s conference. As with previous conference agendas, ...
(Date:2/26/2015)... (NASDAQ: CYBX ) today announced results for the ... Operating results for the third quarter of fiscal 2015 compared ... include: , Worldwide net sales of $72.1 million, an ... net sales reached $57.6 million, an increase of 9%, with ... country order, international sales increased by 18% on a constant ...
Breaking Medicine Technology:Updates on Pharma Stocks -- Johnson and Johnson, Teva Pharma Industries, Endo Intl., Allergan, and Depomed 2Updates on Pharma Stocks -- Johnson and Johnson, Teva Pharma Industries, Endo Intl., Allergan, and Depomed 3Updates on Pharma Stocks -- Johnson and Johnson, Teva Pharma Industries, Endo Intl., Allergan, and Depomed 4Updates on Pharma Stocks -- Johnson and Johnson, Teva Pharma Industries, Endo Intl., Allergan, and Depomed 5UE Systems Renowned "Ultrasound World" Conference Celebrates its 11th Year 2Cyberonics Reports Fiscal 2015 Third Quarter Results 2Cyberonics Reports Fiscal 2015 Third Quarter Results 3Cyberonics Reports Fiscal 2015 Third Quarter Results 4Cyberonics Reports Fiscal 2015 Third Quarter Results 5Cyberonics Reports Fiscal 2015 Third Quarter Results 6Cyberonics Reports Fiscal 2015 Third Quarter Results 7Cyberonics Reports Fiscal 2015 Third Quarter Results 8Cyberonics Reports Fiscal 2015 Third Quarter Results 9Cyberonics Reports Fiscal 2015 Third Quarter Results 10Cyberonics Reports Fiscal 2015 Third Quarter Results 11Cyberonics Reports Fiscal 2015 Third Quarter Results 12Cyberonics Reports Fiscal 2015 Third Quarter Results 13Cyberonics Reports Fiscal 2015 Third Quarter Results 14Cyberonics Reports Fiscal 2015 Third Quarter Results 15Cyberonics Reports Fiscal 2015 Third Quarter Results 16Cyberonics Reports Fiscal 2015 Third Quarter Results 17Cyberonics Reports Fiscal 2015 Third Quarter Results 18Cyberonics Reports Fiscal 2015 Third Quarter Results 19
Cached News: